Scsp Lux Genpar Atlantic General Net Worth & Insider Trades
Scsp Lux Genpar Atlantic General Centessa Pharmaceuticals Plc
What is Scsp Lux Genpar Atlantic General's Net Worth?
The current estimated net worth of Centessa Pharmaceuticals Plc's Scsp Lux Genpar Atlantic General is estimated to be about $1.26B . Scsp Lux Genpar Atlantic General owns about 9,681,818 units of Centessa Pharmaceuticals Plc common stock. In the last year at Centessa Pharmaceuticals Plc, Scsp Lux Genpar Atlantic General has sold an estimated value of $0 worth.
What is Scsp Lux Genpar Atlantic General's Past Insider Trading?
Scsp Lux Genpar Atlantic General's largest purchase order was 1,500,000 units , worth over $30M on June 3, 2021. In total, Scsp Lux Genpar Atlantic General has made about 2 transactions over a year of their time at Centessa Pharmaceuticals Plc. Scsp Lux Genpar Atlantic General usually trades in July and June, with the busiest year in 2021 and 2022.
GAP Bermuda LP, GENERAL ATLANTIC GENPAR BERMUDA LP, rl Sa Lux Atlantic General, SCSp Lux GenPar Atlantic General, General Atlantic Cooperatief LP, General Atlantic Partners Lux SCSp, General Atlantic Partners Bermuda EU LP, General Atlantic Partners Bermuda IV LP, UA Cooperatief Atlantic General, BV UM Atlantic General
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Scsp Lux Genpar Atlantic General's' Mailing Address?
- Mailing address is 412f Route D'Esch Luxembourg N4 2086 Luxembourg
What are Centessa Pharmaceuticals Plc's Past Insider Trades?
Centessa Pharmaceuticals Plc's most recent insider trade came on June 2, 2023 by Antoine Yver who sold 6,500 units worth $28.95K . In the last 2 years, insiders at Centessa Pharmaceuticals Plc have sold an estimated value of $1.93M and bought an estimated value of $75.13M worth of shares. Insider trading is most common in February, with the busiest year in 2022. The most active traders at the company are Antoine Yver, EVP & Chairman Development, Tia Bush, Chief Quality Officer, and David Grainger, Chief Innovation Officer .
Centessa Pharmaceuticals plc Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||